You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glucocorticoid therapy reduction/withdrawal

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)

Recruiting
  • Eosinophilic Granulomatosis With Polyangiitis
  • Paris, France
    Hôpital Cochin
Feb 9, 2022

NSCLC, Immunotherapy Trial in Ann Arbor (Dexamthasone)

Terminated
  • Non-Small Cell Lung Cancer
  • Immunotherapy
  • Ann Arbor, Michigan
    VA Ann Arbor Healthcare System, Ann Arbor, MI
Jan 6, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023

Glucocorticoid Withdrawal Syndrome in Treated Cushing Syndrome

Recruiting
  • Cushing Syndrome
  • MUSE biofeedback
  • Rochester, Minnesota
    Mayo Clinic
Oct 31, 2022

RheumatoId Arthritis Trial in France (GlucoCorticoid)

Completed
  • RheumatoId Arthritis
  • Bordeaux, France
  • +16 more
Feb 28, 2022

Chronic Insomnia, Hypnotic Dependence Trial in Lausanne (Medium duration withdrawal programme with ACT, Long duration withdrawal

Active, not recruiting
  • Chronic Insomnia
  • Hypnotic Dependence
  • Medium duration withdrawal programme with ACT
  • +3 more
  • Lausanne, Switzerland
    PROSOM
Oct 13, 2022

Renal Transplantation Trial in United States (Alemtuzumab, rabbit antithymocyte globulin, Belatacept)

Completed
Has Results
  • Renal Transplantation
  • San Francisco, California
  • +7 more
Jul 8, 2021

Uveitis, Metformin, Glucocorticoid Trial in Tianjin (Metformin, Placebo)

Recruiting
  • Uveitis
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Eye Hospital
May 5, 2022

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing

Recruiting
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • ANCA-Associated Glomerulonephritis
  • Chongqing, Chongqing, China
    Children's Hospital of Chongqing Medical University
Jul 23, 2023

Heart Failure, Cardiomyopathy, Dilated, Cardiomyopathies Trial (Other)

Not yet recruiting
  • Heart Failure
  • +3 more
  • (no location specified)
Oct 17, 2023

Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Withdrawal;Drug
  • Imatinib withdrawal
  • +2 more
  • Brno, Czechia
  • +7 more
Aug 24, 2022

ST Elevation Myocardial Infarction, Inflammatory Response, Myocardial Reperfusion Injury Trial (Methylprednisolone, Isotonic

Not yet recruiting
  • ST Elevation Myocardial Infarction
  • +3 more
  • (no location specified)
Aug 4, 2022

Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) Trial in Worldwide (IFX-1, Placebo-IFX-1, Glucocorticoid

Completed
Has Results
  • Granulomatosis With Polyangiitis (GPA)
  • Microscopic Polyangiitis (MPA)
  • Leuven, Belgium
  • +75 more
Aug 3, 2022

Sarcoidosis Trial in Chandigarh (Low dose prednisolone, Medium dose prednisolone)

Completed
  • Sarcoidosis
  • Low dose prednisolone
  • Medium dose prednisolone
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Jan 7, 2023

Lupus Nephritis Trial in Bucharest (Rituximab, Mycophenolate Mofetil, Cyclophosphamide)

Recruiting
  • Lupus Nephritis
  • Bucharest, Romania
    Fundeni Clinical Institute
Mar 2, 2022

Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)

Not yet recruiting
  • Opioid Use Disorder
  • Opioid Withdrawal
  • BXCL501 (180 micrograms)
  • +3 more
  • (no location specified)
Jan 24, 2023

Inflammatory Disorder, Autoimmune Trial in Germany, Switzerland (Prednisone, Placebo Arm)

Recruiting
  • Inflammatory Disorder
  • Autoimmune
  • Frankfurt, Germany
  • +14 more
May 17, 2022

Pulmonary Disease, Chronic Obstructive, Adverse Effect of Glucocorticoids and Synthetic Analogues, Disease Exacerbation Trial in

Recruiting
  • Pulmonary Disease, Chronic Obstructive
  • +2 more
  • Liestal, BL, Switzerland
    Kantonsspital Baselland
Jul 28, 2021

Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

Recruiting
  • Graves Ophthalmopathy
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • MethylPREDNISolone Injectable Solution
  • Milano, MI, Italy
  • +3 more
Aug 3, 2022

Hyperkalaemia and Its Impact on Therapy With RAASi

Recruiting
  • Hyperkalaemia
  • +2 more
    • Portsmouth, United Kingdom
      Portsmouth Hospitals University NHS Trust
    Nov 10, 2022

    Sarcoidosis Trial in Palo Alto (Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1, Placebos)

    Active, not recruiting
    • Sarcoidosis
    • Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1
    • Placebos
    • Palo Alto, California
      Stanford University
    Jan 12, 2022

    Reduced-dose Alemtuzumab for Kidney Transplant Rejection

    Not yet recruiting
    • Kidney Transplant Rejection
      • (no location specified)
      Oct 25, 2023

      Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

      Not yet recruiting
      • Immune Thrombocytopenia
      • Treatment
      • Obinutuzumab Injection [Gazyva]
      • Tianjin, China
        Chinese Academy of Medical Science and Blood Disease Hospital
      Aug 9, 2023

      Cardiotoxicity, HER2-positive Breast Cancer, Heart Failure Trial in London (Phased withdrawal of heart failure medications)

      Not yet recruiting
      • Cardiotoxicity
      • +3 more
      • Phased withdrawal of heart failure medications
      • London, United Kingdom
      • +1 more
      May 19, 2023